Pyrrolidines
Search Within Results
1
–
1
of
1
results
1
Medchemexpress LLC 7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide | 1012054-59-9 | MFCD15528940 | 99.1% | 434.49 g/mol | C24H26N4O4 | 25 MG
CUDC-101 is a small-molecule inhibitor that concurrently targets histone deacetylases (HDACs) and receptor tyrosine kinases EGFR and HER2, used in biochemical and cell-based research. It is supplied as a solid and as DMSO solutions and is intended for research use only (not for human or clinical use).
- Dual inhibition of HDAC and EGFR/HER2 for pathway-specific studies.
- Potent activity with reported IC50s: HDAC 4.4 nM, EGFR 2.4 nM, HER2 15.7 nM.
- High purity (~99%) suitable for sensitive assays.
- Available in small milligram quantities and DMSO solutions for assay preparation.
- Formulated for laboratory research; follow safety data sheet guidance for handling.
